ELTX position history
The shares of Elicio Therapeutics (ELTX) that Shah Capital Management reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2026 Q3: 1,250,000 shares, $2.3M, 0.38% of portfolio, New
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|